28045618
2017 Feb
Intrahepatic lesions of hepatocellular carcinoma (HCC) have been controlled by significant advances in treatment using loco-regional therapies, including, surgery, ablative therapy, catheter-based chemotherapy, and embolization. Consequently, the number of patients with extrahepatic metastatic lesions has increased. Their prognosis remains poor with approximately
AFP; Hepatocellular carcinoma; L3; brain metastasis; radiation; surgery; tumor marker.
